Gilead Sciences $GILD

Health Care · Biotechnology · NASDAQ

S&P 500 Nasdaq-100
Create a scorecard
$151.00
-0.22 (-0.15%)
As of Sep 5, 2026, 1:48 PM EDT
Price history
Loading chart…

Gilead Sciences (GILD) is trading down at $151.00 (-0.15%) on NASDAQ, as of the latest quote. It is a S&P 500 constituent in the Health Care sector.

About Gilead Sciences

Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19. It also develops medicines in therapeutic areas such as oncology and inflammation and cell therapy.

Source: Wikipedia — Gilead Sciences

Recent News (20)

More Health Care stocks

Browse all companies →